The second Russian vaccine for "Corona" will conclude its clinical trials at the end of this month

 The head of the Russian Authority for the Protection of Consumer Rights, Anna Popova, announced that the second vaccine against the emerging corona virus, produced by the specialist center, "Victor", will pass clinical tests by September 30th.

"So far, our colleagues are focusing on trials of a single vaccine, the peptide vaccine, which is a vaccine that relies on the peptide antigen (a small protein that stimulates the immune system to produce powerful antagonists), and it is taking place today in the clinical trials department, and the closing day will be in," Popova said. September 30. "

It is reported that the Russian President, Vladimir Putin, had announced late last month, the imminent emergence of a second Russian vaccine against the coronavirus, confirming his confidence that the second vaccine would be reliable and effective.

On August 11, the Russian Ministry of Health registered the first vaccine in the world to prevent coronavirus infection "Covid-19".

The first vaccine was called "Sputnik-V", and it was the result of the efforts of experts at the "Gamali" Center for Epidemiology and Microbiology Research, in cooperation with the Russian Fund for Direct Investments.

The head of the Federal Authority for Consumer Rights Protection had clarified on a previous occasion the purpose of producing a new vaccine after the "Sputnik-V" vaccine developed by the "Gamali" Center, saying: "It is absolutely certain that every country must have, including Russia, several different vaccines, which is what we are doing today. "

Follow our latest local and sports news, and the latest political and economic developments via Google news